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TO THE EDITOR
In JID advance online publication, 14
August 2008, the report by Lu et al.
entitled ‘‘Tumorigenic Effect of Some
Commonly Used Moisturizing Creams
when Applied Topically to UVB-Pre-
treated High-Risk Mice’’ contains cer-
tain misleading statements that have
been damaging to attitudes toward
products used by the public for decades
without any reported association with
skin cancer or any other form of
tumorigenesis. The reported study com-
pares hairless mice pretreated with
UVB radiation and then treated for 17
weeks with either of four commonly
used moisturizers—Dermovan, Derma-
base, Eucerin, and Vanicream—or a
new ‘‘Custom Blend’’ formulation cre-
ated by Johnson & Johnson and stated
by the authors to be nontumorigenic.
The title of the report is itself mislead-
ing, because tumorigenesis was in-
itiated not by the moisturizing creams
but by irradiation with UVB. Then, the
first statement in the introduction ad-
dresses sunlight-induced human skin
cancer, although the focus of the study
is on tumorigenesis in high-risk mice.
Also, in the introduction of their report
Lu et al. refer to an animal test model
‘‘that resembles humans who receive
extensive exposure to sunlight early in
life and develop skin cancers later in
life,’’ and in the discussion section they
refer again to ‘‘sunlight-induced skin
cancer in humans.’’ The emphasis on
the relevance of this report to human
skin cancers tends to set a false
impression of the importance of the
reported observations in the high-risk
mice. The hairless mouse is a mutant
that is highly sensitive toward the
development of skin tumors, and the
decades-long human use of the tested
moisturizers without any reported ob-
servation of a relationship to tumor
development, either malignant or be-
nign, clearly leaves the observations of
this report on mice without any rele-
vance to tumorigenesis in humans.
The reported data show that 85% of
27 untreated control mice, 77% of 30
water-treated control mice, and
72–90% of moisturizer-treated mice
developed tumors. With such large
percentages of both test and control
mice developing tumors and the dis-
parity between the two groups of
control mice, the comparison of test
mice to control mice is of very little, if
any, importance.
Specifically in reference to Vani-
cream, the reported data show that 83%
of Vanicream-treated UVB-pretreated
mice and 85% of untreated control mice
developed skin tumors: 83% of the
Vanicream-treated mice and 85% of the
untreated control mice developed non-
malignant skin tumors, and as many
water-treated control mice (5 of 30) as
Vanicream-treated mice (5 of 30) devel-
oped cancerous tumors. Of the five
Vanicream-treated mice that developed
cancerous tumors, each had one cancer-
ous tumor, whereas four of the five water-
treated control mice had one cancerous
tumor each and one had two cancerous
tumors. Three of the untreated control
mice developed one cancerous tumor
each and one developed two cancerous
tumors. The data in this report clearly do
not show Vanicream to have been
carcinogenic in the high-risk mice. Also,
this report shows that Vanicream did not
increase the numbers of UVB-pretreated
hairless mice that developed nonmalig-
nant tumors. In addition, although all 30
of the Vanicream-treated mice survived
until termination of the study, 3 of the 30
untreated control mice and 5 of the 30
mice treated with the ‘‘nontumorigenic’’
Johnson & Johnson Custom Blend cream
perished, and neither the tumor status of
those mice nor the cause of death was
revealed by Lu et al.
Similarly, in reference to Eucerin,
the reported data show that 79% of the
Eucerin-treated UVB-pretreated mice
developed tumors compared to 85%
of untreated control mice and 77% of
water-treated control mice, and no
evidence was shown to implicate Eu-
cerin as being carcinogenic. The data
on Dermabase-treated and Dermovan-
treated mice raise more questions on
the validity of the report.
Lu et al. have stated that the number
of tumors formed per mouse and the
volume of the tumors were increased by
the postradiation treatments with moist-
urizers; however, from the data as pre-
sented in tabular form, fully meaningful
comparisons are not possible, because
the average values presented are mean
values, and for each set of mice, a small
number of extreme values could have
biased the mean value extensively. More-
over, as calculated from the tabulated
standard error of the mean, the range of
each set of values for the moisturizer-
treated mice (mean±2 standard devia-
tion) and the range for each group of
control mice are very broad and overlap
fully. Therefore, a real-life significance of
the differences between mean values of
moisturizer-treated mice and of control
mice is doubtful.
Two additional factors of major
significance have been ignored or over-
looked by the authors of this report.
First, Lu et al. have not shown their
observations to be reproducible. Sec-
ond, a blinding of the identification of
the moisturizers and placebos was notAbbreviation: UVB, ultraviolet light of the wavelength range 290–320 nanometers
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included in the execution of the re-
ported study.
Finally, Lu et al. stated in the closing of
the discussion section the ‘‘significance
for humans has not been established’’ as
though there were any significance for
humans. This suggestion and the earlier
comments in this report about relevance
to human skin cancer have inflicted
unjustifiable damage to the reputations
of the tested moisturizers, according to
many commentaries in the lay press and
correspondence to the manufacturers.
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TO THE EDITOR
Although Dr Ellefson believes that the
title of our paper is misleading, our title
does accurately describe our findings.
Dr Ellefson also expresses concern
about the high sensitivity of the hairless
mouse to tumor development. The
SKH-1 hairless mouse has been a useful
model for sunlight-induced skin cancer
for many years. These mice do not
develop skin tumors in the absence of
UVB irradiation or treatment with a
carcinogen, and the skin of SKH-1 mice
have many similarities to human skin in
their response to UVB radiation. Ex-
posure of SKH-1 mouse skin or human
skin to UVB results in similar biochem-
ical/molecular effects such as formation
of thymine dimers in DNA, increases in
wild-type p53, mutations in the p53
gene, and apoptosis in DNA-damaged
cells. In addition, UVB-induced skin
tumors in SKH-1 mice and sunlight-
induced skin tumors in humans have a
similar profile of mutations in the p53
gene.
Although there are similarities in the
response of mouse and human skin
to UVB, there are also differences.
Concerning the relevance of our
study for humans, we indicated in our
article that ‘‘It should be emphasized
that our study as well as the other studies
described here were only done in
hairless SKH-1 mice, and their signi-
ficance for humans has not been
established. Further studies are needed
to determine the effects of the wide-
spread use of moisturizing creams on
the risk of sunlight induced skin cancer
in humans.’’
The suggestion by Dr Ellefson that
‘‘the decades-long human use of the
tested moisturizers without any re-
ported observation of a relationship to
tumor development’’ indicates a lack of
tumorigenicity of these products in
humans may be because the possible
tumorigenicity of these products in
humans has not received careful atten-
tion by epidemiologists. Our publica-
tion provides a rationale for a careful
study by epidemiologists to determine
whether or not the use of moisturizing
creams contributes to the high inci-
dence of sunlight-induced skin cancer
in humans.
Dr Ellefson correctly points out that
at the end of our study (after treatment
of high-risk mice with water or creams
for 17 weeks), there were no statisti-
cally significant differences in the per-
centage of mice that had tumors (Tables
2 and 4). Since most of the mice had
tumors after 17 weeks of treatment, it is
possible/likely that differences would
have been observed if the mice had
been killed at an earlier time. In any
case, treatment of the high-risk mice
with each of the commercially avail-
able creams caused a statistically sig-
nificant increase in the rate of tumor
formation (Figure 1) and in the number
of histologically characterized tumors
at the end of the study (Tables 2 and 4).
Concerning reproducibility, we found
that treatment of high-risk mice with
Dermabase for 17 weeks in experiment
1 increased the number of histologi-
cally characterized tumors per mouse
by 79% (Po0.0001), and when the
study was repeated more than a year
later, treatment with Dermabase in-
creased the number of histologically
characterized tumors per mouse by
59% (Po0.0001). We believe this is
reasonably good reproducibility.
The main purpose of our study was to
find a nontumorigenic cream that could
be used for a cancer chemoprevention
study in humans. We were surprised to
find tumorigenic activity of several
commercially available creams when
they were applied topically to UVB-
pretreated mice. This effect may have
been caused by certain tumor promoters
such as long-chain alkanes in mineral oil
and petrolatum as well as by sodium
lauryl sulfate. Tumor-promoting effects
of long-chain alkanes and sodium lauryl
sulfate have been reported (Slaga, 1983),
and a tumorigenic effect of mineral oil
has also been reported when adminis-
tered during a UVB carcinogenesis study
(Kligman and Kligman, 1992).
The major issue concerning our pub-
lication is whether or not it indicates a
potential cancer risk for the use of
moisturizing creams in humans. We have
been very conservative in describing the
major conclusions of our study, and we
have indicated in our paper that we do
not know whether our study in SKH-1
mice is relevant for humans. It is regret-
table that the press has greatly exaggerated
the meaning of our study. In discussing
our results with the press and with others,
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